We provide longitudinal patient-level data that gives teams greater confidence in treatment dynamics, unmet need and decision priorities.
When every patient counts, confidence in the data matters
Our longitudinal patient-level data helps teams see what is changing, where value, opportunity and risk are building, and where to focus next.
Flexible coverage
Programmes can include priority HCP groups, treatment settings or institutions and apply a consistent approach across countries.
Patient-level visibility across diseases, cohorts and markets
Tudor’s HCP-led approach can be applied across disease areas, specialties, care settings and markets, subject to feasibility.
Rare diseases
Capture detailed patient histories and ongoing management in rare and very uncommon conditions.
Niche cohorts
Use targeted sampling and HCP engagement to bring priority patient groups into clearer view.
Oncology
Understand complex diagnostic and treatment pathways, including disease stage, sequencing, switching and progression.
Broader disease areas
Apply the same patient-level approach across common and specialist conditions.
Built with Confidence
Tudor Data follows patients forward, so change is measured rather than inferred
We apply structured checks across recruitment, patient capture, sample change and output interpretation so clients have confidence in how they can use the data.
Patient and HCP confidentiality
No direct patient identifiers are captured. Identifiers used for follow-up are held only by the participating HCP.
Human oversight
Experienced researchers maintain oversight of study design, clinical relevance, data quality and interpretation.
Controlled use of AI
AI supports programme setup and quality checks under human oversight. Patient and client data are not used to train external AI models.